No Data
No Data
Bristol Myers Stock Trading Near 52-Week High: Time to Buy or Sell?
10-Q: Q3 2024 Earnings Report
8-K: Bristol Myers Squibb Reports Third Quarter Financial Results for 2024
BRISTOL-MYERS SQUIBB CO USD2 CNV CUM PFD USD1 (BMYMP.US) will release earnings reports before the market opens on October 31st.
$BRISTOL-MYERS SQUIBB CO USD2 CNV CUM PFD USD1(BMYMP.US)$ will release its financial report before the market opens on October 31st, investors please pay attention. How was the previous performance? $BRISTOL-MYERS SQUIBB CO USD2 CNV CUM PFD USD1(BMYMP.US)$ revenue for 2024/Q2 was $12.201 billion, with a net income of $1.684 billion. Revenue for 2023/Q3 was $10.966 billion.
BRISTOL-MYERS SQUIBB CO USD2 CNV CUM PFD USD1 To Go Ex-Dividend On November 5th, 2024 With 0.5 USD Dividend Per Share
Bristol-Myers Squibb Company PFD CONV 2 Goes Ex Dividend Tomorrow
No Data
No Data